United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services
Go back to United Therapeutics Announces FDA Approval Of XPS™ And Steen Solution™ Used To Perform Centralized Ex-Vivo Lung Perfusion Services| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 487.61 -2.63 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $490.24 | 52 Week High | $164.04 | |||
| Open | $484.33 | 52 Week Low | $97.52 | |||
| Day High | $494.09 | P/E | 89.14 | |||
| Day Low | $484.33 | EPS | $5.47 | |||
| Volume | 327,025 | |||||
